Skip to main content

Home›Research›Compare›Davunetide vs N-Acetyl Semax

Peptide Comparison

Davunetide vs N-Acetyl Semax

Both are Neuro & Cognitive peptides.

Davunetide

NAP

CognitiveInvestigationalResearch Only

No providers listed yet

Full Davunetide profile →
vs

N-Acetyl Semax

NA-Semax

CognitiveResearch Only

10 providers listed

Full N-Acetyl Semax profile →
Bottom line

Davunetide has published research citations on file; N-Acetyl Semax does not yet — the main evidence gap between them.

Quick Verdict

Davunetide

N-Acetyl Semax

Which One Should You Choose?
Your goalBetter option
Has published research citationsDavunetide
Further along in FDA reviewDavunetide
More provider options (0 vs 10)N-Acetyl Semax

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Davunetide
N-Acetyl Semax
Mechanism Family
Neuro & Cognitive
Neuro & Cognitive
Half-life
—
—
FDA Status
investigational
unknown
Admin Routes
intranasal, subcutaneous
intranasal, subcutaneous
Availability
Research Only
Research Only
Providers
None listed
10 listed
Research Evidence

Davunetide

RCT · 3 key studies · most recent 2026

N-Acetyl Semax

No citations on file
Research Citations

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Research Areas
neuroprotectiontau stabilizationcognitive enhancementmemorysynaptic plasticity

About N-Acetyl Semax

Same ACTH(4-7) core as Semax, but structural modifications resist peptidase degradation. Enhances BDNF expression, supports dopaminergic and serotonergic neurotransmission, and modulates NMDA receptor activity.

Research Areas
BDNF and NGF upregulation extrapolated from parent compound semax researchdopaminergic and serotonergic modulation (semax mechanism basis)acetylation proposed to improve enzymatic stability vs base semaxno independent PubMed evidence for this specific modified compound
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Davunetide

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

N-Acetyl Semax

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.